← Back to Search

GSDG multi-component intervention for Alcohol Use Disorder (GSDG Trial)

N/A
Waitlist Available
Led By Ted Miller, Ph.D.
Research Sponsored by HBSA
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

GSDG Trial Summary

This trial will study the effects of a multi-faceted approach to reducing alcohol use and related harms in 6 cities. The intervention will include screening and brief interventions by health providers, evidence-based interventions, and novel or partially tested interventions. Key outcomes of interest include alcohol-related harms such as motor vehicle crashes and fatalities, heavy/binge drinking, underage drinking, and drinking and driving.

Eligible Conditions
  • Alcohol Use Disorder

GSDG Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Health and social harms related to alcohol use
Secondary outcome measures
Alcohol expectancies
Awareness of alcohol health guidance labels and information
Awareness of alcohol policies
+7 more

GSDG Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: GSDG InterventionExperimental Treatment1 Intervention
Cities receiving a multi-component intervention, including screening and brief intervention, other evidence-based interventions (e.g., enforcement of drink-driving or underage drinking laws), and novel or partially tested interventions that warrant further evaluation.
Group II: ComparisonActive Control1 Intervention
Comparison cities receiving no evidence-based interventions.

Find a Location

Who is running the clinical trial?

HBSALead Sponsor
1 Previous Clinical Trials
27,012 Total Patients Enrolled
Ted Miller, Ph.D.Principal InvestigatorHBSA

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is participation in this investigational trial still being accepted?

"Affirmative. According to the clinicaltrials.gov portal, this research endeavour is presently recruiting volunteers; it was initially announced on September 1st 2017 and amended most recently on March 16th 2022. 36000 individuals are needed for enrollment across one particular site."

Answered by AI

How many participants has this research study recruited?

"Affirmative. Clinicaltrials.gov records that this medical trial, initially set up on September 1st 2017, is presently recruiting applicants. 36000 participants are needed from a single clinical site."

Answered by AI
~4747 spots leftby Apr 2025